It then maps shared CRC–T2DM nodes (insulin/IGF signaling, AMPK–mTOR crosstalk, inflammation, microbiome-driven biotransformation) to justify urolithins as dual-purpose modulators. The gene discussed is INS; the disease is type 2 diabetes mellitus.